Advisory: Ignore incorrect advisory alert on Beyond Cancer coding error

Beyond Air

03/12/2024 22:57

An incorrect advisory alert saying Beyond Cancer's clinical
trial approval was wrongly tagged to Beyond Air  XAIR.O  has
been withdrawn.
    Beyond Cancer is a unit of biopharma company Beyond Air, and
the original alert from Beyond Cancer's press release was
correctly coded.
    For the correctly coded alert on Beyond Cancer's clinical
trial approval, click  urn:newsml:reuters.com:*:nFWN3N415S
    
    STORY_NUMBER: nFWN3N410N
    STORY_DATE: 03/12/2024
    STORY_TIME: 09:14:12 PM GMT

 ((bangalore.newsroom@thomsonreuters.com))